| 6541 | CITI GCP_Inter | | 05/04/2023 19:34:37 | |
| 6542 | CITI_USFDA | | 05/04/2023 19:35:33 | |
| 6543 | CITI_IRBmem | | 05/04/2023 19:36:51 | |
| 6544 | CITI RCR | | 05/04/2023 19:37:38 | |
| 6545 | CITI refresher | | 05/04/2023 19:55:37 | |
| 6546 | GCP | | 05/04/2023 21:50:44 | |
| 6547 | Good Clinical Practice & Human Subject Protection Training Program 2022 | | 06/04/2023 12:46:15 | |
| 6548 | COLLABORATIVE INSTITUTIONAL TRAINING INITIATIVE | | 06/04/2023 15:18:14 | |
| 6549 | Good Clinical Practice and Human Subject Protection Training Program | | 06/04/2023 18:52:56 | |
| 6550 | วิทยาศาสตรมหาบัณฑิต | | 06/04/2023 22:20:34 | |
| 6551 | “Good Clinical Practice & Human Subject Protection Training Program 2022” | | 07/04/2023 08:10:35 | |
| 6552 | GCP online training | | 07/04/2023 10:49:32 | |
| 6553 | CITI conflicts of interest | | 07/04/2023 12:55:38 | |
| 6554 | GCP for clinical involving drugs (ICH focus) | | 07/04/2023 12:56:34 | |
| 6555 | IRB members | | 07/04/2023 12:57:17 | |
| 6556 | GCP US-FDA focus | | 07/04/2023 12:58:03 | |
| 6557 | แนวทางการปฎิบัติการวิจัยทางคลินิกที่ดี | | 07/04/2023 20:19:42 | |
| 6558 | Good Clinical Practice & Human Subject Protection Training Program 2022” | | 08/04/2023 11:09:02 | |
| 6559 | Human Subject Protection (HSP) | | 08/04/2023 15:41:25 | |
| 6560 | CPG | | 08/04/2023 21:35:14 | |
